MPM Capital L.P. is a US-based healthcare investment firm specializing in venture capital for therapeutic areas. The firm invests in both private and public biotech companies that are developing innovative, life-saving drugs. MPM Capital typically engages in Series A through Series E funding rounds, with a significant focus on early-stage investments, including seed rounds.

Notable portfolio companies include 23andMe, Acorda Therapeutics, and ElevateBio. The firm is led by experienced partners who bring a wealth of knowledge from previous affiliations with leading biotech and pharmaceutical companies. MPM Capital offers unique value-add services such as strategic guidance and industry connections to help portfolio companies navigate the complex landscape of drug development and commercialization.